| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = -$1 ) |
| | 2027 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA258981 | The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML | 000 | 5 | NIH | 10/20/2026 | $0 |
| | 2027 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK134652 | Role of trefoil factor family proteins in beta cell function. | 000 | 4 | NIH | 10/13/2026 | $0 |
| | 2027 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R00AR084575 | Investigating the Role of Cancer-Associated Fibroblasts in Immunodetection of Mycosis Fungoides | 000 | 3 | NIH | 10/16/2026 | $0 |
| | 2027 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA258778 | Targeting tumor-associated macrophages for triple-negative breast cancer treatment | 000 | 5 | NIH | 11/11/2026 | $0 |
| | 2027 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA279840 | Okazaki fragment maturation: mutagenesis and cell survival | 000 | 4 | NIH | 11/4/2026 | $0 |
| | 2027 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R03DE034794 | Protein Phosphoribosylation: Characterization of a novel protein modification | 000 | 2 | NIH | 11/6/2026 | $0 |
| | 2027 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U24DK104162 | Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN). | 000 | 13 | NIH | 10/30/2026 | $0 |
| | 2027 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U24DK104162 | Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN). | 000 | 13 | NIH | 10/30/2026 | $0 |
| | 2027 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA265095 | Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia | 000 | 5 | NIH | 10/20/2026 | $0 |
| | 2027 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA205247 | Targeting MicroRNAs to Eradicate Leukemia Stem Cells | 000 | 9 | NIH | 10/20/2026 | $0 |
| | 2027 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA262754 | The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma | 000 | 5 | NIH | 10/14/2026 | $0 |
| | 2027 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R21CA293969 | Modulating Intratumoral Immune Composition to Enhance Immunotherapy | 000 | 1 | NIH | 10/23/2026 | $0 |
| | 2027 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R21AR084116 | Concurrent eradication of pathogenic plasma cells and their precursors in systemic lupus erythematosus | 000 | 1 | NIH | 10/20/2026 | $0 |
| | 2027 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | K08CA252157 | Multi-antigen-specific CAR T cells to treat acute myeloid leukemia | 000 | 5 | NIH | 10/21/2026 | $0 |
| | 2027 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R21AR084116 | Concurrent eradication of pathogenic plasma cells and their precursors in systemic lupus erythematosus | 000 | 1 | NIH | 10/20/2026 | $0 |
| | 2027 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL124112 | Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease | 000 | 11 | NIH | 11/9/2026 | $0 |
| | 2027 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK125856 | Circulating Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes | 000 | 4 | NIH | 10/26/2026 | -$1 |
|
 | Issue Date FY: 2026 ( Subtotal = $88,372,540 ) (Continued on the next page) |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R37CA284040 | Air Pollution and Neighborhood Stressors as Determinants of Non-Small Cell Lung Cancer (NSCLC) Mutation Patterns and Recurrence | 000 | 3 | NIH | 5/7/2026 | $1,179,028 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA286160 | Targeting Immune Escape in CML/MPN Transformation | 001 | 3 | NIH | 4/17/2026 | $57,161 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA286160 | Targeting Immune Escape in CML/MPN Transformation | 000 | 3 | NIH | 12/12/2025 | $514,454 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R35GM156498 | Emergent role of allostery on function of GPCRs and Trimeric G proteins | 002 | 2 | NIH | 3/10/2026 | $44,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R35GM156498 | Emergent role of allostery on function of GPCRs and Trimeric G proteins | 001 | 2 | NIH | 1/22/2026 | $400,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA258981 | The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML | 001 | 5 | NIH | 4/16/2026 | $54,289 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA258981 | The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML | 000 | 5 | NIH | 12/22/2025 | $488,601 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA279595 | Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia | 001 | 3 | NIH | 4/16/2026 | $70,805 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA279595 | Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia | 000 | 3 | NIH | 12/15/2025 | $637,252 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R50CA285409 | Leading NCI Clinical Trials Network research nationally and at the City of Hope Comprehensive Cancer Center | 000 | 3 | NIH | 9/1/2026 | $208,103 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | K23AI163343 | Cytomegalovirus-specific Immune Reconstitution after Hematopoietic Cell Transplantation in the Era of Modern Antiviral Prophylaxis | 001 | 7 | NIH | 1/26/2026 | $187,540 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R37CA276517 | Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies | 000 | 4 | NIH | 7/7/2026 | $438,242 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK138665 | Targeting bile acid composition to treat metabolic diseases | 000 | 3 | NIH | 12/18/2025 | $665,898 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | P01HL170046 | Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation | 000 | 3 | NIH | 8/14/2026 | $2,364,370 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U24DK098085 | Integrated Islet Distribution Program (U24) - 2021 | 002 | 8 | NIH | 8/27/2026 | $2,885,999 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA241845 | Validation of epigenomic biomarkers for thyroid cancer diagnostics | 002 | 5 | NIH | 9/23/2026 | $0 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA241845 | Validation of epigenomic biomarkers for thyroid cancer diagnostics | 001 | 5 | NIH | 4/16/2026 | $81,787 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA241845 | Validation of epigenomic biomarkers for thyroid cancer diagnostics | 000 | 5 | NIH | 12/10/2025 | $736,086 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA261793 | Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer | 001 | 5 | NIH | 6/26/2026 | $512,135 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R37CA292678 | The role, mechanism, and therapeutic potential of METTL1 in acute myeloid leukemia | 000 | 3 | NIH | 7/1/2026 | $429,139 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | UM1CA186717 | Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN | 001 | 9 | NIH | 6/11/2026 | $1,915,725 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U54CA285116 | 1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership | 000 | 4 | NIH | 9/9/2026 | $1,380,456 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266665 | Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer | 002 | 5 | NIH | 9/16/2026 | $61,818 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266665 | Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer | 001 | 5 | NIH | 1/28/2026 | $556,363 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL162847 | Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD | 000 | 4 | NIH | 6/10/2026 | $839,592 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL162847 | Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD | 001 | 4 | NIH | 6/18/2026 | $0 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA258778 | Targeting tumor-associated macrophages for triple-negative breast cancer treatment | 001 | 5 | NIH | 4/16/2026 | $51,959 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA258778 | Targeting tumor-associated macrophages for triple-negative breast cancer treatment | 000 | 5 | NIH | 12/11/2025 | $467,633 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01NS134116 | Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation | 000 | 4 | NIH | 8/14/2026 | $571,835 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R25CA275711 | Cancer Aging and Metabolism research experience Program (CAMP) | 001 | 3 | NIH | 6/12/2026 | $231,762 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | P30CA033572 | Cancer Center Support Grant | 003 | 43 | NIH | 6/29/2026 | $221,720 |
|